WHO endorses protocol for Coronavirus herbal medicine trials


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ who-endorses-protocol-coronavirus-herbal-medicine-trials
Covid-19 has raised the issue of using traditional medicines to battle contemporary diseases, and the endorsement clearly encouraged testing

The World Health Organization endorsed Saturday a protocol for testing African herbal medicines as potential treatments for the coronavirus and other epidemics.

Covid-19 has raised the issue of using traditional medicines to battle contemporary diseases, and the endorsement encouraged testing with criteria similar to those used for molecules developed by labs in Asia, Europe, or the Americas.

It came months after a bid by the president of Madagascar to promote a drink based on Artemisia, a plant with proven efficacy in malaria treatment, was met with widespread scorn.

On Saturday, WHO experts and colleagues from two other organizations "endorsed a protocol for phase III clinical trials of herbal medicine for Covid-19 as well as a charter and terms of reference for the establishment of a data and safety monitoring board for herbal medicine clinical trials," a statement said.

"Phase III clinical trials are pivotal in fully assessing the safety and efficacy of a new medical product," it noted.

"If a traditional medicine product is found to be safe, efficacious, and quality-assured, WHO will recommend (it) for a fast-tracked, large-scale local manufacturing," Prosper Tumusiime, a regional WHO director, was quoted as saying.

WHO's partners are the Africa Centre for Disease Control and Prevention and the African Union Commission for Social Affairs.

"The onset of Covid-19, like the Ebola outbreak in West Africa, has highlighted the need for strengthened health systems and accelerated research and development programs, including on traditional medicines," Tumusiime said.

He did not refer specifically to the Madagascar drink Covid-Organics, also called CVO, that President Andry Rajoelina has pitched as a cure for the virus, however.

It has has been widely distributed in Madagascar and sold to several other countries, mainly in Africa.

In May, WHO Africa Director Matshidiso Moeti told media that African governments had committed in 2000 to take "traditional therapies" through the same clinical trials as other medication.

"I can understand the need, the drive to find something that can help," Moeti said. "But we would very much like to encourage this scientific process in which the governments themselves committed."

Tags : #WHO #Africa #COVID-19 #Trials #Protocol

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026